Efficacy of levosimendan in cardiac failure after heart valve surgery.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 29 Aug 2009 Primary endpoint 'disease occurrence' has been met.
- 29 Aug 2009 Results have been presented at ESC Congress 2009: Annual Congress of the European Society of Cardiology.
- 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.